Page 5 - Accidental Ingestion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accidental ingestion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accidental Ingestion Today - Breaking & Trending Today

Statement from Akebia Therapeutics Regarding Litigation Against Centers for Medicare & Medicaid Services and the U.S. Department of Health and Human Services

/PRNewswire/ At Akebia Therapeutics, we are driven by a collective purpose to better the lives of people impacted by kidney disease. As part of our charge. ....

United States , United Kingdom , Mercedes Carrasco , Centers For Medicare Medicaid Services , American Kidney Fund , Us Department Of Health , Human Services , Us Court , Biotechnology Innovation Organization , National Kidney Foundation , Massachusetts Biotechnology Council , Akebia Therapeutics , Medicaid Services , First Circuit , Medicare Advocacy Project , Greater Boston Legal Services , Medicare Advocacy , Dialysis Patient Citizens , National Kidney , Children Due , Accidental Ingestion , Deficiency Anemia , Health Care Amp Hospitals , Biotechnology , Medical Pharmaceuticals , Health Insurance ,

Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones

Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Davida Spellman , Stevenk Burke , Kristenk Sheppard , Johnp Butler , Drug Administration , Research Development , Exchange Commission , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , European Medicines Agency , Virtual Congress , European Renal Association , England Journal , Chief Executive Officer , Senior Vice President , Chief Medical Officer , Otsuka Pharmaceutical , Marketing Authorization Application , Business Highlights , Prescription Drug User Fee Act , Transplant Association , Chief Financial Officer , New Drug Application , Chronic Kidney Disease ,

Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones

Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
- Vadadustat New Drug Application (NDA) submitted to the U.S. Food and Drug Administration (FDA)
- Results of global Phase 3 programs for vadadustat published in New England Journal of Medicine
- Conference call today at 9:00 a.m. ET
News provided by
Share this article
®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the first quarter ended March 31, 2021 and highlighted recent corporate milestones. The Company will host a conference call today, Monday, May 10, 2021, at 9:00 a.m. Eastern Time. ....

United States , United Kingdom , Davida Spellman , Leannem Zumwalt , Kristenk Sheppard , Johnp Butler , Mitsubishi Tanabe Pharma Corporation , Group Vice , Drug Administration , Akebia Medical Affairs , Exchange Commission , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , Healthcare Royalty Management , Japan Ministry Of Health , European Medicines Agency , Government Affairs At Davita Inc , Otsuka Pharmaceutical , New England Journal , Chief Executive Officer , Marketing Authorization Application , Business Highlights , Group Vice President , Government Affairs , Engagement Hub , Akebia Medical ,

Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates

Share this article
CAMBRIDGE, Mass., Feb. 25, 2021 /PRNewswire/
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for the fourth quarter and full-year ended December 31, 2020 and provided business updates. The Company will host a conference call today, Thursday, February 25, 2021, at 9:00 a.m. Eastern Time.
Akebia also announced a $60 million non-dilutive transaction with an entity managed by HealthCare Royalty Management, LLC (HCR), to monetize the Company s rights to receive royalties and sales milestones on vadadustat net sales under its collaboration agreement with Mitsubishi Tanabe Pharma Corporation (MTPC). MTPC has the exclusive rights to commercialize vadadustat in Japan, where it is currently marketed under the trade name Vafseo™ (vadadustat), and certain other Asian countries. Under the terms of the agreement with HCR, Ak ....

United States , United Kingdom , Leanne Zumwalt , Davida Spellman , Leannem Zumwalt , Kristenk Sheppard , Johnp Butler , Mitsubishi Tanabe Pharma Corporation , Group Vice , Drug Administration , Akebia Medical Affairs , Exchange Commission , Akebia Therapeutics Inc , Otsuka Pharmaceutical Co , Healthcare Royalty Management , Japan Ministry Of Health , European Medicines Agency , American Society Of Nephrology Kidney Week , Government Affairs At Davita Inc , Chief Executive Officer , New Drug Application , Otsuka Pharmaceutical , Marketing Authorization Application , Business Highlights , Group Vice President , Government Affairs ,